Compare INKT & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INKT | NTIC |
|---|---|---|
| Founded | 2017 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.6M | 83.1M |
| IPO Year | 2021 | 1996 |
| Metric | INKT | NTIC |
|---|---|---|
| Price | $12.50 | $8.24 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 38.0K | 11.9K |
| Earning Date | 05-15-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $84,234,474.00 |
| Revenue This Year | N/A | $12.49 |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | ★ N/A | $412.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.80 | $7.14 |
| 52 Week High | $76.00 | $10.03 |
| Indicator | INKT | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.49 | 65.40 |
| Support Level | $10.82 | $7.85 |
| Resistance Level | $12.45 | $8.53 |
| Average True Range (ATR) | 0.83 | 0.14 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 45.36 | 93.46 |
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.